Mathematical model reveals the role of memory CD8 T cell populations in recall responses to influenza

Frontiers in Immunology

Volumn 7, Issue MAY, 2016, Pages

  Zarnitsyna, Veronika I ^a   Handel, Andreas ^b   McMaster, Sean R ^a   Hayward, Sarah L ^a   Kohlmeier, Jacob E ^a   Antia, Rustom ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Central memory; Influenza; Recall response; Resident memory; T cell

Indexed keywords

ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; IMMUNE RESPONSE; INFLUENZA; MATHEMATICAL MODEL; MEMORY T LYMPHOCYTE; SECONDARY INFECTION; VIRAL CLEARANCE; VIRUS LOAD;

EID: 84973557311     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00165     Document Type: Article

References (47)

1. WHO. (2015). Available from: http://www.who.int/mediacentre/factsheets/fs211/en/
2. Brooke CB, Yewdell JW. Host versus flu: antibodies win a round? Nat Struct Mol Biol (2013) 20(3):245-6. doi: 10.1038/nsmb.2524
3. Grebe KM, Yewdell JW, Bennink JR. Heterosubtypic immunity to influenza A virus: where do we stand? Microbes Infect (2008) 10(9):1024-9. doi:10.1016/j.micinf.2008.07.002
4. Eichelberger M, Allan W, Zijlstra M, Jaenisch R, Doherty PC. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J Exp Med (1991) 174(4):875-80. doi:10.1084/jem.174.4.875
5. Scherle PA, Palladino G, Gerhard W. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J Immunol (1992) 148(1):212-7
6. Epstein SL, Lo CY, Misplon JA, Bennink JR. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J Immunol (1998) 160:322-7
7. Mozdzanowska K, Maiese K, Gerhard W. Th cell-deficient mice control influenza virus infection more effectively than Th-and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance. J Immunol (2000) 164:2635-43. doi:10.4049/jimmunol.164.5.2635
8. Assarsson E, Bui H-H, Sidney J, Zhang Q, Glenn J, Oseroff C, et al. Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J Virol (2008) 82(24):12241-51. doi:10.1128/JVI.01563-08
9. Gianfrani C, Oseroff C, Sidney J, Chesnut RW, Sette A. Human memory CTL response specific for influenza A virus is broad and multispecific. Hum Immunol (2000) 61(5):438-52. doi:10.1016/S0198-8859(00)00105-1
10. 2 influenza viruses. J Gen Virol (2013) 94:583-92. doi:10.1099/vir.0.048652-0
11. Zweerink HJ, Courtneidge SA, Skehel JJ, Crumpton MJ, Askonas BA. Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses. Nature (1977) 267(5609):354-6. doi:10.1038/267354a0
12. 2) virus is mediated by virus-specific T-cells. J Gen Virol (2011) 92:2339-49. doi:10.1099/vir.0.033076-0
13. Kreijtz JHCM, Bodewes R, van Amerongen G, Kuiken T, Fouchier RAM, Osterhaus ADME, et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine (2007) 25(4):612-20. doi:10.1016/j.vaccine.2006.08.036
14. 2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus. Vaccine (2009) 27(36):4983-9. doi:10.1016/j.vaccine.2009.05.079
15. Liang S, Mozdzanowska K, Palladino G, Gerhard W. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J Immunol (1994) 152(4):1653-61
16. 2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets. J Virol (2011) 85(6):2695-702. doi:10.1128/JVI.02371-10
17. Weinfurter JT, Brunner K, Capuano SV III, Li C, Broman KW, Kawaoka Y, et al. Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates. PLoS Pathog (2011) 7(11):e1002381. doi:10.1371/journal.ppat.1002381
18. 2 pandemic of 1957: an experiment of nature. J Infect Dis (2006) 193(1):49-53. doi:10.1086/498980
19. McMichael AJ, Gotch FM, Noble GR, Beare PA. Cytotoxic T-cell immunity to influenza. N Engl J Med (1983) 309(1):13-7. doi:10.1056/NEJM198307073090103
20. Baccam P, Beauchemin C, Macken CA, Hayden FG, Perelson AS. Kinetics of influenza A virus infection in humans. J Virol (2006) 80(15):7590-9. doi:10.1128/JVI.01623-05
21. Pawelek KA, Huynh GT, Quinlivan M, Cullinane A, Rong L, Perelson AS. Modeling within-host dynamics of influenza virus infection including immune responses. PLoS Comput Biol (2012) 8(6):e1002588. doi:10.1371/journal.pcbi.1002588
22. Saenz RA, Quinlivan M, Elton D, Macrae S, Blunden AS, Mumford JA, et al. Dynamics of influenza virus infection and pathology. J Virol (2010) 84(8):3974-83. doi:10.1128/JVI.02078-09
23. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melén K, Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev (2001) 12(2-3):171-80. doi:10.1016/S1359-6101(00)00026-5
24. Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski UH, et al. Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol (2003) 170:2022-9. doi:10.4049/jimmunol.170.4.2022
25. Snyder CM, Cho KS, Bonnett EL, Allan JE, Hill AB. Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog (2011) 7:e1002295. doi:10.1371/journal.ppat.1002295
26. Antia R, Ganusov VV, Ahmed R. The role of models in understanding CD8+ T-cell memory. Nat Rev Immunol (2005) 5(2):101-11. doi:10.1038/nri1550
27. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, et al. A human memory T cell subset with stem cell-like properties. Nat Med (2011) 17:1290-7. doi:10.1038/nm.2446
28. Sallusto F, Lanzavecchia A. Memory in disguise. Nat Med (2011) 17:1182-3. doi:10.1038/nm.2502
29. Farber DL, Yudanin NA, Restifo NP. Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol (2014) 14:24-35. doi:10.1038/nri3567
30. Doherty PC, Topham DJ, Tripp RA. Establishment and persistence of virus-specific CD4+ and CD8+ T cell memory. Immunol Rev (1996) 150:23-44. doi:10.1111/j.1600-065X.1996.tb00694.x
31. Jiang X, Clark RA, Liu L, Wagers AJ, Fuhlbrigge RC, Kupper TS. Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature (2012) 483(7388):227-31. doi:10.1038/nature10851
32. Kaufman DR, Liu J, Carville A, Mansfield KG, Havenga MJE, Goudsmit J, et al. Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination. J Immunol (2008) 181(6):4188-98. doi:10.4049/jimmunol.181.6.4188
33. Masopust D, Vezys V, Marzo AL, Lefrançois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science (2001) 291(5512):2413-7. doi:10.1126/science.1058867
34. Hogan RJ, Usherwood EJ, Zhong W, Roberts AA, Dutton RW, Harmsen AG, et al. Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J Immunol (2001) 166(3):1813-22. doi:10.4049/jimmunol.166.3.1813
35. Marshall DR, Turner SJ, Belz GT, Wingo S, Andreansky S, Sangster MY, et al. Measuring the diaspora for virus-specific CD8+ T cells. Proc Natl Acad Sci U S A (2001) 98(11):6313-8. doi:10.1073/pnas.101132698
36. Zammit DJ, Turner DL, Klonowski KD, Lefrançois L, Cauley LS. Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity (2006) 24(4):439-49. doi:10.1016/j.immuni.2006.01.015
37. 2) antibody responses from cross-sectional data. PLoS Biol (2015) 13(3):e1002082. doi:10.1371/journal.pbio.1002082
38. McMichael AJ, Gotch FM, Dongworth DW, Clark A, Potter CW. Declining T-cell immunity to influenza, 1977-82. Lancet (1983) 2(8353):762-4. doi:10.1016/S0140-6736(83)92297-3
39. van de Sandt CE, Hillaire MLB, Geelhoed-Mieras MM, Osterhaus ADME, Fouchier RAM, Rimmelzwaan GF. Human influenza A virus-specific CD8+ T-cell response is long-lived. J Infect Dis (2015) 212(1):81-5. doi:10.1093/infdis/jiv018
40. Corti D, Suguitan AL Jr, Pinna D, Silacci C, Fernandez-Rodriguez BM, Vanzetta F, et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest (2010) 120(5):1663-73. doi:10.1172/JCI41902
41. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science (2011) 333(6044):850-6. doi:10.1126/science.1205669
42. Ekiert DC, Bhabha G, Elsliger M-A, Friesen RHE, Jongeneelen M, Throsby M, et al. Antibody recognition of a highly conserved influenza virus epitope. Science (2009) 324(5924):246-51. doi:10.1126/science.1171491
43. Ekiert DC, Friesen RHE, Bhabha G, Kwaks T, Jongeneelen M, Yu W, et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science (2011) 333(6044):843-50. doi:10.1126/science.1204839
44. Okuno Y, Isegawa Y, Sasao F, Ueda S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol (1993) 67(5):2552-8
45. Okuno Y, Matsumoto K, Isegawa Y, Ueda S. Protection against the mouse-adapted a/fm/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains. J Virol (1994) 68(1):517-20
46. Throsby M, van den Brink E, Jongeneelen M, Poon LLM, Alard P, Cornelissen L, et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One (2008) 3(12):e3942. doi:10.1371/journal.pone.0003942
47. Ferguson NM, Galvani AP, Bush RM. Ecological and immunological determinants of influenza evolution. Nature (2003) 422(6930):428-33. doi:10.1038/nature01509